Beloueche-Babari, M., Jamin, Y., Arunan, V., Walker-Samuel, S., Revill, M., Smith, P. D., . . . Robinson, S. P. (2013). Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI. Nature Publishing Group.
Citação norma ChicagoBeloueche-Babari, M., et al. Acute Tumour Response to the MEK1/2 Inhibitor Selumetinib (AZD6244, ARRY-142886) Evaluated By Non-invasive Diffusion-weighted MRI. Nature Publishing Group, 2013.
Deismireacht MLABeloueche-Babari, M., et al. Acute Tumour Response to the MEK1/2 Inhibitor Selumetinib (AZD6244, ARRY-142886) Evaluated By Non-invasive Diffusion-weighted MRI. Nature Publishing Group, 2013.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.